Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,854 GBX | +2.26% | +3.63% | +3.63% |
Apr. 25 | Hikma Pharmaceuticals backs outlook after making strong start to 2024 | AN |
Apr. 25 | Hikma Pharmaceuticals Affirms FY24 Guidance | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.63% | 5B | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Hikma Pharmaceuticals : Wins US Regulatory Approval For Generic Asthma Drug